Dechra Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 1/6
Dechra Pharmaceuticals has a total shareholder equity of £755.2M and total debt of £487.6M, which brings its debt-to-equity ratio to 64.6%. Its total assets and total liabilities are £1.6B and £814.2M respectively. Dechra Pharmaceuticals's EBIT is £17.1M making its interest coverage ratio 0.8. It has cash and short-term investments of £74.4M.
Key information
64.6%
Debt to equity ratio
UK£487.60m
Debt
| Interest coverage ratio | 0.8x |
| Cash | UK£74.40m |
| Equity | UK£755.20m |
| Total liabilities | UK£814.20m |
| Total assets | UK£1.57b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DPHL's short term assets (£467.9M) exceed its short term liabilities (£164.0M).
Long Term Liabilities: DPHL's short term assets (£467.9M) do not cover its long term liabilities (£650.2M).
Debt to Equity History and Analysis
Debt Level: DPHL's net debt to equity ratio (54.7%) is considered high.
Reducing Debt: DPHL's debt to equity ratio has increased from 57.6% to 64.6% over the past 5 years.
Debt Coverage: DPHL's debt is not well covered by operating cash flow (13%).
Interest Coverage: DPHL's interest payments on its debt are not well covered by EBIT (0.8x coverage).